Test Price
450 AED✅ Home Collection Available
Immunophenotyping by Flow Cytometry (CD7) Test in UAE | 450 AED | DHA Licensed
Executive Summary & Core Metrics
- ✔ Diagnostics guarantee: 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139)
- ✔ Premium logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- ✔ Clinical support: Telephonic post‑test clinical guidance for result interpretation
- ✔ Insurance: Direct billing verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This test employs multi-parametric flow cytometry to precisely identify and quantify CD7-positive cells in peripheral blood or bone marrow aspirates. It provides critical diagnostic and monitoring information for haematological malignancies, chiefly T-cell acute lymphoblastic leukaemia (T-ALL) and specific lymphomas. The methodology delivers a quantitative immunophenotypic profile with 99.9% sensitivity, enabling precise lineage assignment and minimal residual disease detection.
| Feature | Our Test (CD7 Flow Cytometry) | Closest Alternative (Immunohistochemistry) |
|---|---|---|
| Precision | Multi‑parametric single‑cell quantification, 99.9% sensitivity | Semi‑quantitative, tissue‑based |
| Methodology | Fluorescent flow cytometry (gold standard) | Enzyme‑linked antibody staining |
| Turnaround | Next Business Day (if sample received by 9 AM) | 2–4 working days |
Physician Insight & Safety Protocols
“Interpretation of CD7 expression requires careful integration with the complete haematological profile. While CD7 is a sensitive marker for T-cell lineage malignancies, it is not specific in isolation and must be correlated with morphology, cytogenetics, and other immunophenotypic markers to avoid diagnostic pitfalls. This test should always be used as part of a comprehensive diagnostic work-up.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Pre-Test Clinical Advisory
Medication Management
Do not alter or discontinue prescribed therapy without prior consultation with your treating physician. Certain medications, including immunosuppressants and chemotherapeutic agents, can modulate cell surface marker expression and impact test results. Full disclosure of your current medication regimen to the laboratory is mandatory.
Exclusion Criteria & Red Flags
- Collection via bone marrow aspiration is contraindicated in patients with severe coagulopathy or bleeding disorders.
- Active systemic infections may compromise cell viability and result accuracy.
- Emergency Red Flags: Fever >38.5°C with neutropenia, uncontrolled haemorrhage, or acute neurological changes—seek immediate emergency care before proceeding with any diagnostic collection.
- Informed consent is mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the purpose of the CD7 flow cytometry test?
Answer: CD7 immunophenotyping provides decisive evidence for classifying T-cell leukaemia and lymphoma subtypes. It guides treatment selection and monitors minimal residual disease with high precision when interpreted alongside complete blood counts and bone marrow biopsy.
2. How should I prepare for this test?
Answer: No fasting is required. However, you must provide a complete clinical history and a current medication list. Avoid strenuous exercise for 24 hours before the blood draw to prevent transient immune cell shifts that could affect interpretation.
3. What does a positive result mean?
Answer: A positive CD7 result indicates an elevated number of CD7-expressing cells. Your haematologist will integrate this finding with cytogenetic and molecular markers to confirm a diagnosis and design a personalised treatment protocol. A positive result alone does not definitively diagnose malignancy without full clinical correlation.
UAE Regulatory & Data Privacy Adherence
Data confidentiality and security: DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for the processing and storage of all patient health information.
Clinical safety and governance: All laboratory procedures and patient consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring the highest standards of clinical safety and legal compliance.
Clinical & Logistical Metadata
| Test Name | Immunophenotyping by Flow Cytometry (CD7) |
| Price (AED) | 450 |
| Turnaround Time | Next Business Day (if sample received by 9 AM) |
| Sample Type / Matrix | Peripheral Blood or Bone Marrow Aspirate. Collection Environment: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Multi-parametric Flow Cytometry |
| ICD-10-CM Code | C91.9 |
| LOINC Code | 8113-5 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians